November 12, 2020 | posted by MediPrint Opthalmics
IND Paves the Way to Phase 2a Clinical Study and Seed Round Lead Advances Company’s Efforts for Its Proprietary Continuous Ocular Drug Delivery Portfolio FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (Business Wire, November 12th, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based pharmaceutical company focused on helping protect sight, announces the achievement […]
August 5, 2020 | posted by MediPrint Opthalmics
External Thought Leaders to Help Guide Progress on Company’s Proprietary Continuous Ocular Drug Delivery Portfolio FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (Business Wire August 5th, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based pharmaceutical company focused on helping protect sight, announces the expansion of its Scientific Advisory Board (SAB) that now comprises […]
June 23, 2020 | posted by MediPrint Opthalmics
Patented product for the novel treatment of glaucoma is IND-ready
April 15, 2020 | posted by MediPrint Opthalmics
Accomplished Ophthalmic Executive to Lead Company in Its Next Phase
February 20, 2020 | posted by MediPrint Opthalmics
Leo Lens Pharma Strengthens its Pipeline with New IP Protection for a Unique Atropine-based Myopia Management Solution February 19, 2020 08:51 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice of allowance from the USPTO for a patent for the use […]
November 12, 2019 | posted by MediPrint Opthalmics
FOR IMMEDIATE RELEASE Leo Lens Technology Selected as Finalist for Connect’s 2019 Most Innovative New Product Awards Unique Drug Delivery Contact Lens Product is a Finalist in the Life Sciences & Healthtech Category SAN DIEGO, CA, USA (NOVEMBER 11, 2019) – Today, Leo Lens Technology announced that its unique drug delivery contact lens product has […]